Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Talon Therapeutics, Inc. | tlon_10q-033111.htm |
| EX-31.1 - EXHIBIT 31.1 - Talon Therapeutics, Inc. | ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Talon Therapeutics, Inc. | ex31-2.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Talon Therapeutics, Inc. does hereby certify that to the best of his knowledge:
(a) the Quarterly Report on Form 10-Q of Talon Therapeutics, Inc. for the three months ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Talon Therapeutics, Inc.
|
Dated: May 13, 2011
|
/s/ Steven R. Deitcher, MD
|
|
Steven R. Deitcher, MD
|
|
|
President and Chief Executive Officer
|
|
|
Dated: May 13, 2011
|
/s/ Craig W. Carlson
|
|
Craig W. Carlson
Senior Vice President, Chief Financial Officer
|